The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine

The Journal of Infectious Diseases
Kenneth E SchmaderC Peter Watson

Abstract

Worldwide, herpes zoster (HZ) affects millions of patients (particularly older adults) annually and causes significant suffering due to acute and chronic pain, or postherpetic neuralgia (PHN). The objective of this article is to explain the rationale for the HZ vaccine by summarizing data on the epidemiology of HZ in the immunocompetent host, with a focus on recent incidence and risk factor studies; to review information on the burden of HZ; and to discuss the challenges of lessening the morbidity of the disease. The incidence and severity of HZ and PHN are highest in older adults. Given the central nervous system damage caused by HZ, the difficulty of adequately treating HZ to prevent PHN, and the intractability of PHN, the advent of the HZ vaccine appears to be a crucial innovation for preventing HZ and PHN.

References

Mar 1, 1990·Clinical Pharmacology and Therapeutics·R Kishore-KumarR Dubner
Nov 1, 1990·Journal of the American Geriatrics Society·K SchmaderH J Cohen
Aug 1, 1988·Pain·C P WatsonR J Evans
Jun 1, 1982·Neurology·C P WatsonJ Warsh
Jul 1, 1995·Antimicrobial Agents and Chemotherapy·K R BeutnerM J Wood
Feb 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·E LydickC J White
Dec 1, 1994·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·J MauskopfR Berzon
Mar 1, 1995·The Journal of Infectious Diseases·K SchmaderJ D Hamilton
Aug 26, 1998·Journal of the American Geriatrics Society·K SchmaderC F Pieper
Dec 8, 1998·The Journal of Infectious Diseases·R J WhitleyJ W Gnann
Dec 10, 1998·JAMA : the Journal of the American Medical Association·M RowbothamL Magnus-Miller
Jul 7, 1994·PharmacoEconomics·L DaviesM Drummond
Sep 29, 2000·BMJ : British Medical Journal·A L Cunningham, R H Dworkin
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C ChidiacC de Labareyre
Nov 6, 2001·Epidemiology and Infection·M BrissonG De Serres
Dec 18, 2001·European Journal of Pain : EJP·K Meyer-RosbergA Kristofferson
Jun 18, 2002·Journal of Pain and Symptom Management·Renee A DesmondRichard J Whitley
Aug 2, 2002·The New England Journal of Medicine·John W Gnann, Richard J Whitley
Mar 11, 2003·Journal of Medical Virology·M Brisson, W J Edmunds
Mar 11, 2003·Journal of Medical Virology·Fiona T ScottJudith Breuer
May 15, 2003·Vaccine·Rachel S ChapmanDouglas M Fleming
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Anne Louise OaklanderMark P Jensen
Nov 25, 2003·Journal of Medical Virology·Satish K MehtaDuane L Pierson
Jan 15, 2004·The Lancet Infectious Diseases·Sara L Thomas, Andrew J Hall
Jan 27, 2004·BMJ : British Medical Journal·S L ThomasAndrew J Hall
May 12, 2004·Neurology·Beth F JungRobert H Dworkin
Jul 29, 2004·AIDS·Martyn A FrenchShelley F Stone
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jennifer KatzRobert H Dworkin
Sep 1, 2004·The Journal of Pain : Official Journal of the American Pain Society·Paul M CoplanMichael N Oxman
Apr 9, 2005·Epidemiology and Infection·J P MulloolyH Houston
Jun 3, 2005·The New England Journal of Medicine·M N OxmanUNKNOWN Shingles Prevention Study Group
Jun 10, 2005·The Journal of Pain : Official Journal of the American Pain Society·Gerry OsterPaul D Cleary
Jul 30, 2005·Journal of General Internal Medicine·Ralph P InsingaAlexander A Nikas
Aug 10, 2005·Neurology·James D Berry, Karin Lottrup Petersen
Sep 28, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kelly A GeboMichael J Polydefkis

❮ Previous
Next ❯

Citations

Dec 29, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Bernhard UltschOle Wichmann
Nov 23, 2013·Médecine et maladies infectieuses·C RabaudJ Gaillat
Oct 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ada DelaneySusan M Fleetwood-Walker
Feb 10, 2010·Nature Reviews. Rheumatology·Seo Young Kim, Daniel H Solomon
Jan 12, 2013·The Journal of Infectious Diseases·John X ZhangRafael Harpaz
Apr 17, 2013·BMC Geriatrics·Renske EilersHester E de Melker
May 30, 2009·BMC Medicine·Paolo BonanniPeter Wutzler
Jun 23, 2010·BMC Medicine·Robert W JohnsonThomas Weinke
Sep 19, 2008·Cases Journal·George PanagouliasSpiros S Ladas
Jan 1, 2012·Pain Management·Robert W Johnson, Kazuo Higa
Jan 7, 2014·European Journal of Internal Medicine·Susanna EspositoUNKNOWN ESCMID Vaccine Study Group (EVASG)
Jun 27, 2009·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Sum Lam, Tomas Z Jodlowski
Jul 24, 2012·Zeitschrift für Gesundheitswissenschaften = Journal of public health·Kati LukasIsabelle Bertrand
Apr 25, 2012·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Benny Katz
May 15, 2013·Mayo Clinic Proceedings·Barbara P YawnLinda C Butterfield
Apr 1, 2011·Journal of the American Medical Directors Association·Liyuan MaKenneth E Schmader
Oct 27, 2009·The Journal of Pain : Official Journal of the American Pain Society·Robert H DworkinSissi V Pham
Jul 17, 2009·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Thomas J Liesegang
Nov 26, 2008·La Presse médicale·Pierre-Olivier LangJean-Pierre Michel
Jan 5, 2011·Pain Practice : the Official Journal of World Institute of Pain·Gisèle Pickering, Alain Leplege
May 17, 2011·Journal of the American Geriatrics Society·Robert H DworkinSissi V Pham
Mar 20, 2010·Musculoskeletal Care·Deborah Bond, Janice Mooney
Oct 7, 2015·Aging Clinical and Experimental Research·UNKNOWN Herpes Zoster and Functional Decline Consortium
May 7, 2014·Scandinavian Journal of Infectious Diseases·Trung N TranLaurel A Habel
Apr 17, 2015·BMC Public Health·Adam GaterEmmanuelle Préaud
Jun 22, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Axel C MühlbacherMatthias Nübling
Feb 15, 2015·Vaccine·Chien-An YaoKuo-Chin Huang
Aug 7, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B Weinberger, B Grubeck-Loebenstein
Jan 31, 2008·The Journal of Pain : Official Journal of the American Pain Society·Kenneth E Schmader, Robert H Dworkin
Jul 21, 2014·BMC Infectious Diseases·Adam GaterRobert Johnson
Dec 8, 2016·Human Vaccines & Immunotherapeutics·Cristiano AlicinoGiancarlo Icardi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.